We are live on ! Find out more
OSCR icon

Oscar Health

263 hedge funds and large institutions have $2.62B invested in Oscar Health in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 98 increasing their positions, 71 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $78M | Put options by funds: $56.2M

38% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 71

5.82% more ownership

Funds ownership: 86.27%92.08% (+5.8%)

7% less funds holding

Funds holding: 284263 (-21)

22% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 77

31% less capital invested

Capital invested by funds: $3.78B → $2.62B (-$1.16B)

33% less funds holding in top 10

Funds holding in top 10: 128 (-4)

Holders
263
Holders Change
-21
Holders Change %
-7.39%
% of All Funds
3.46%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
60
Increased
98
Reduced
71
Closed
77
Calls
$78M
Puts
$56.2M
Net Calls
+$21.9M
Net Calls Change
-$34.6M
Name Holding Trade Value Shares
Change
Change in
Stake
DLCIG
276
D.L. Carlson Investment Group
New Hampshire
-$3.93M -185,224 Closed
MAP
277
Moody Aldrich Partners
Massachusetts
-$3.15M -148,318 Closed
YIH
278
Y-Intercept (HK)
Hong Kong
-$2.76M -130,338 Closed
PCM
279
Penserra Capital Management
California
-$2.25M -106,193 Closed
CCA
280
Catalyst Capital Advisors
New York
-$1.98M -93,460 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
281
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.95M -92,100 Closed
PCM
282
Prelude Capital Management
New York
-$1.23M -57,958 Closed
BCM
283
Bayesian Capital Management
New York
-$1.17M -55,316 Closed
SEC
284
Seven Eight Capital
New York
-$1.12M -52,828 Closed
NIM
285
NEOS Investment Management
Connecticut
-$930K -43,854 Closed
UWM
286
Udine Wealth Management
Florida
-$925K -43,622 Closed
CIP
287
Convergence Investment Partners
Florida
-$874K -41,222 Closed
SG Americas Securities
288
SG Americas Securities
New York
-$873K -41,164 Closed
RP
289
Regal Partners
Australia
-$809K -38,155 Closed
GCP
290
GSA Capital Partners
United Kingdom
-$796K -37,508 Closed
II
291
Inspire Investing
Idaho
-$780K -36,779 Closed
DFCM
292
Dark Forest Capital Management
Puerto Rico
-$743K -35,050 Closed
CIM
293
Cambria Investment Management
California
-$736K -34,705 Closed
SRL
294
Scientech Research LLC
New Jersey
-$726K -34,215 Closed
Los Angeles Capital Management
295
Los Angeles Capital Management
California
-$627K -29,561 Closed
HighTower Advisors
296
HighTower Advisors
Illinois
-$600K -28,584 Closed
CMF
297
Counterpoint Mutual Funds
California
-$522K -24,598 Closed
Corient Private Wealth
298
Corient Private Wealth
Florida
-$482K -22,741 Closed
BHCM
299
Brevan Howard Capital Management
Jersey
-$478K -22,525 Closed
Envestnet Asset Management
300
Envestnet Asset Management
Illinois
-$449K -21,151 Closed

OSCR Hedge Fund Activity: Q4 2024 in Review

263 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q4 2024, worth a combined $2.62B — down 31% from $3.78B a quarter earlier.

Sellers outnumbered buyers: 77 funds closed out of OSCR and 60 opened new positions — a net loss of 17 holders — while 71 trimmed existing stakes and 98 added.

The largest buyer was JP Morgan Chase, adding an estimated $130M. The largest seller was Citadel Advisors, cutting an estimated $65M.

  • 263 institutional investors held Oscar Health (OSCR) as of Q4 2024, down from 284 in Q3 2024.
  • Funds reported $2.62B of Oscar Health stock for Q4 2024, down 31% quarter-over-quarter.
  • 60 funds opened new Oscar Health positions in Q4 2024 and 77 closed out, a net change of -17 holders.
  • The largest Oscar Health buyer in Q4 2024 was JP Morgan Chase, an estimated $130M added.
  • The largest Oscar Health seller in Q4 2024 was Citadel Advisors, an estimated $65M sold.

Based on aggregated 13F filings for Q4 2024.